Tirzepatide (Mounjaro) 5mg

Tirzepatide (Mounjaro) 5mg

Tirzepatide 5mg is a dual incretin receptor agonist used in clinical settings to support blood glucose control and metabolic health. It is the active compound found in the branded medication Mounjaro, widely prescribed for type 2 diabetes management and studied for weight-related metabolic benefits.

🔬 Key Benefits (Clinical Context)

• Improves blood sugar control (type 2 diabetes management)
• Supports appetite regulation and reduced food intake
• Enhances insulin sensitivity and glucose metabolism
• Studied for body weight and metabolic health outcomes

⚙️ Mechanism of Action

Tirzepatide activates two key hormone pathways:

• GIP (glucose-dependent insulinotropic polypeptide)
• GLP-1 (glucagon-like peptide-1)

This dual action leads to:

• Increased insulin secretion (glucose-dependent)
• Reduced glucagon levels
• Slowed gastric emptying
• Increased satiety and reduced appetite

🧬 Product Details

• Active ingredient: Tirzepatide
• Strength: 5 mg
• Class: Dual GIP/GLP-1 receptor agonist
• Form: Injectable formulation (prescription-based)
• Primary use: Metabolic and glycemic regulation